AstraZeneca''s Evusheld gets approval in EU to treat COVID-19 (NASDAQ:AZN)
The European Commission ((EC)) approved AstraZeneca''s (AZN) Evusheld to treat people aged 12 years and older with COVID‑19 who do not require supplemental oxygen and who are at…
AstraZeneca''s Evusheld gets approval in EU to treat COVID-19 (NASDAQ:AZN)
The European Commission ((EC)) approved AstraZeneca''s (AZN) Evusheld to treat people aged 12 years and older with COVID‑19 who do not require supplemental oxygen and who are at…